Detection of pancreatic cancer with a urine test
Science Focus - 25-Sep-2019Test will be used in a clinical study, if it will get approved, the test will roll out to patients
Tatjana Crnogorac-Jurcevic
Professor of Molecular Pathology at Barts Cancer Institute.
She obtained the MBBS degree and completed an MD thesis at the Medical Faculty, University of Zagreb in Croatia, and her PhD at the Imperial College School of Medicine in London. After a postdoctoral experience in molecular biology at CNRS in Toulouse, France and molecular oncology at CRUK laboratory at Hammersmith Hospital, London, she joined Barts Cancer Institute in November 2004.
Her research focuses on molecular pathology of pancreatic cancer, in particular its development and progression. They are using this knowledge to develop biomarkers for early, non-invasive detection of this malignancy in urine specimens.
Visit website: https://www.bartscancer.london/staff/dr-tatjana-crnogorac-jurcevic/
tatjana-crnogorac-jurcevic-79939312
See also: 
Barts Cancer Institute
- UK cancer research institute.
Details last updated 02-Nov-2019
Tatjana Crnogorac-Jurcevic News
